COVID-19 IgM/IgG Antibody Test Kit (Immunochromatography)

A diagnostic test kit for the detection of IgM and IgG antibodies against SARS-CoV-2 using immunochromatography technology. This in vitro diagnostic kit is used for serological testing and antibody detection in suspected or confirmed COVID-19 cases.

A rapid diagnostic test kit for the detection of SARS-CoV-2 antigens using immunochromatography technology. The kit is designed for quick identification of active SARS-CoV-2 infection in clinical and point-of-care settings.

Rapid immunochromatography test kits for quick detection of specific antigens or antibodies in clinical samples. These point-of-care diagnostic tools deliver results within minutes, supporting infectious disease screening, immunological assessment, and emergency clinical decision-making.

Immunochromatographic test kit for detecting 2019-nCoV neutralizing antibodies in patient samples. Enables rapid qualitative assessment of neutralizing antibody response following infection or vaccination. Provides results through visual interpretation of immunochromatographic strips without instrumental analysis.

Immunochromatography rapid tests for qualitative and semi-quantitative detection of analytes in clinical samples. These lateral flow assays enable point-of-care and laboratory diagnostics with fast turnaround times. Available formats include cassette and strip configurations for drug screening, hormonal, and immunological testing.

Immunochromatography test strips and systems for rapid qualitative or semi-quantitative detection of analytes in clinical specimens. Used in point-of-care diagnostics for disease screening and monitoring. Combines immunoassay principles with chromatographic separation for fast, reliable results.

Rapid immunochromatographic test for qualitative detection of COVID-19 IgG and IgM antibodies in serum, plasma, or whole blood samples. Delivers results in 10-15 minutes, enabling point-of-care screening and confirmation of SARS-CoV-2 infection. CLIA-waived format suitable for clinical laboratories and non-laboratory settings.

Rapid immunochromatographic test device for qualitative detection of COVID-19 IgG and IgM antibodies in human serum, plasma, or whole blood samples. Designed for point-of-care testing in clinical settings, providing results within minutes to support COVID-19 diagnosis and serological screening.

Lateral flow immunochromatography test for simultaneous detection and differentiation of measles IgG and IgM antibodies in whole blood samples. Enables rapid diagnosis of measles infection in clinical settings.

Rapid antigen detection kit for SARS-CoV-2 using colloidal gold immunochromatography. Delivers qualitative results for COVID-19 diagnosis in clinical and point-of-care settings. Designed for swift patient screening and laboratory confirmation protocols.

Rapid immunochromatographic test kit for qualitative detection of SARS-CoV-2 IgM and IgG antibodies in serum, plasma, or whole blood samples. Provides results within 10-15 minutes, enabling quick identification of acute and past coronavirus infections in clinical and point-of-care settings.

A rapid diagnostic test kit for detecting COVID-19 IgG and IgM antibodies. The kit uses colloidal gold immunochromatographic technology with high specificity and sensitivity. It contains test cards with sample wells and can be used for qualitative detection of IgG and IgM antibodies in human samples. Results are indicated by colored bands and can be interpreted as negative, IgM positive, IgG positive, or both IgG and IgM positive.